Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Multiple Myeloma 8Pancreatic Neoplasms 7Neoplasms 6Neoplasms, Plasma Cell 4Myelodysplastic Syndromes 4Colorectal Neoplasms 3Stomatitis 2Skin Neoplasms 2Prostatic Neoplasms 2Ovarian Neoplasms 2Myeloproliferative Disorders 2Leukemia, Myeloid, Acute 2Leukemia 2Inflammation 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Sarcoma 1Recurrence 1Primary Myelofibrosis 1Myofibroma 1Myelodysplastic-Myeloproliferative Diseases 1Multiple Endocrine Neoplasia Type 1 1Mucositis 1Motor Activity 1Lymphoma 1Lung Neoplasms 1Liver Neoplasms 1Limb-girdle muscular dystrophy, type 2C 1

Interventions

Cytarabine 9fludarabine 5Imatinib Mesylate 5thymoglobulin 3fludarabine phosphate 3Tacrolimus 3Sirolimus 3Methotrexate 3Cyclophosphamide 3Busulfan 3Azacitidine 3zosuquidar trihydrochloride 2venetoclax 2ponatinib 2nilotinib 2enasidenib 2bosutinib 2RO6839921 2Mycophenolic Acid 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Etoposide 2Behavior Therapy 2Antilymphocyte Serum 24-methyl-N-(3-(4-methylimidazol-1-yl)-5-trifluoromethylphenyl)-3-(4-pyrazin-2-ylpyrimidin-2-ylamino)benzamide 2spartalizumab 1sabatolimab 1quizartinib 1plerixafor 1pegfilgrastim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leukemia, Myeloid × Ascorbic Acid × Clear all
NCT03613727 2023-11-07

Therapeutic Use of Intravenous Vitamin C in Allogeneic Stem Cell Transplant Recipients

Virginia Commonwealth University

Phase 2 Completed
61 enrolled 11 charts
Classical hematologyOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Graft vs Host Disease, Leukemia, Lymphoid, Leukemia, Monocytic, Acute, Leukemia, Myeloid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡